- Uncontrollable stress in healthcare workers may be a legal hazard, researchers argue
- Baptist Health Richmond names chief medical officer
- 101 hospital and health system chief pharmacy officers to know | 2026
- 21 new behavioral health study findings to know
- 32 behavioral health executive moves to know
- 7 Medicaid behavioral health fraud cases, audit findings to know
- Beyond alarm management: How Elizabeth Seton Children’s Center turned surveillance data into personalized pediatric care
- What’s next for Rush’s retiring CEO
- Healthcare billing fraud: 10 recent cases
- Assort Health raises $120M
- HCA Florida hospital taps COO
- 48 recent hospital, health system executive moves
- How long does it take to sell an ASC?
- Why 34 health systems bet big on GI in 2026
- Lung cancer screening, mortality and incidence — by state
- My Community Dental Centers appoints new CEO
- 42 North Dental appoints chief marketing officer
- Physicians vs. prior authorization: 10 updates
- Physicians, not hospitals, are driving practice acquisitions: Study
- ADA backs federal healthcare workforce bill
- Standard Dental Labs plans acquisition of Florida lab
- The states where physicians earn the most after taxes
- Where 6 cardiology advocacy efforts stand now: ACC
- Leadership training, insurance, bonuses and more: What the best dental workplaces offer employees
- UM Health-Sparrow receives record gift for behavioral health hospital
- US psychiatrist workforce to meet 42.8% of projected demand by 2037: Study
- 14 new behavioral health projects to know
- What hospital-employed physicians regret most after an acquisition: Study
- Heartland Dental opens Ohio practice
- Eugene Gastroenterology Consultants opens new ASC
- CRNAs are leaving hospital jobs — where are they going?
- 5 DSOs making headlines
- 2 physicians pay $2.2M to settle claims of medically unnecessary surgical procedures
- Cancer Drug Shortage Renews Calls For Federal Action
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Sanofi under antitrust probe as European Commission kicks off formal proceedings
- Weekly Rundown: Innovaccer, AWS ink strategic collaboration; Mount Sinai adopts Signal 1 for AI management
- Industry Voices—What Pope Leo’s AI encyclical could mean for healthcare: 3 key takeaways for leaders
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
- Efforts To End School Vaccine Mandates Hit a Wall in Florida
- Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
- Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
- Eli Lilly taps AI to bring personal memories to life during its European radio show road trip
- BeOne boosts support for Blood Cancer United with $5M commitment
- Pharma’s Cannes-do attitude sees industry return to triumph
- Biogen launches ‘Ready for More’ HD Spinraza campaign with a focus on how we see SMA
- Senators revive bill targeting expanded methadone access
- DSOs gain new funding to fuel growth: 3 updates
- Montana hospital to end dental services due to financial constraints
- Rhode Island expands reimbursement options for public health hygienists
- 2 behavioral health providers to affiliate under Boundless name
- 5 states targeting Medicaid behavioral health enrollment amid fraud concerns
- Arizona behavioral health clinic suspended from Medicaid amid fraud allegations
- Cassidy's new plan to overhaul 340B: Rebates, contract pharmacy limits and more changes
- With Medicare's GLP-1 'bridge' coming soon, Walmart expands weight management supports for consumers
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict
- Democrats to propose bill capping out-of-pocket costs for Medicare enrollees
- Upside secures $20M series A to expand healthcare-focused housing platform
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Fosun Pharma plots global push beyond oncology, fueled by multi-asset Alzheimer’s strategy
- FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
- Oracle partners with Theator to expand AI-powered surgical documentation to operating rooms
- Jubilant HollisterStier gets FDA warning letter for quality control problems
- Ionis scores transformational FDA label expansion for Tryngolza
- AstraZeneca spells out a community cancer screening strategy with the YMCA
- Novartis teams up with Becoming rentABLE for its new SMA campaign
- Assort Health scores $120M series C to scale voice AI agent platform for healthcare
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- TigerConnect expands AI-driven platform with new scheduling capabilities
- US health spending set to reach $9T by 2034: CMS report
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- First Stop Health expands weight management program, shares first-year results
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Infinitus launches risk detection system to ensure appropriate patient triage from AI agents
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
Nursing ethics is grounded in "inherent dignity, worth, and unique attributes of every person" (ANA) in alignment with principles of Christian liberty and the American Founding.
Medical ethics is older, and traditionally more disease-focused, self-sustaining, and authoritarian. (4 Principles of Biomedical Ethics) Bioethics in particular has made a bad reputation for itself in association with assisted suicide and reduced standards for organ donation/ declaring brain death.
Lippincott makes a fair comparison between the two codes of ethics.
Both have recently strayed from dedication to the individual in their care, and instead toward population care and ESG (environmental, social justice, and governance).
https://www.medpagetoday.com/opinion/second-opinions/118526
In Memoriam: The Sudden Demise of the AMA Journal of Ethics
— A great loss for physicians, the profession, and the public
November 14, 2025
Bioethics is a small field, but we punch above our weight when it comes to writing. Professional journal articles, reports, and policies are arguably our primary written products, since the main job in bioethics is to help clinicians and others navigate ethical challenges in their work. But we also write for the public, in forums like blogs and editorials, since many of the issues we write about have broader implications. Consequently, learning to write for publication is a key skill for bioethicists, and professional journals are critical for the field. One particular journal -- the AMA Journal of Ethics (AMA JoE) -- has been a stalwart in giving a voice to newcomers to the field.
In late October, without warning, the American Medical Association (AMA) announced that it would cease publishing AMA JoE after the December 2025 issue. Journals like AMA JoE operate a year or more in advance, so multiple authors and editors of upcoming issues for 2026-2027 were left in the lurch by this unexpected announcement. Students and trainees are now scrambling to find new homes for their articles, some of which have already undergone extensive editorial review.
The Birth of AMA JoE
For over 25 years, AMA JoE stood out from the rest of bioethics journals. It was a rare monthly open access journal that tackled a remarkably wide variety of topics. The journal has a unique model where students and trainees competitively apply to edit a theme issue of their choosing, and then they work closely with professional editors to pull each issue together. This requires a great deal of work by these editors-in-training, including selecting and pitching a topic, identifying mentors and contributors, editing manuscripts, and coordinating with the journal's professional staff.
AMA JoE initially launched in 1999 as an innovative online resource, the Virtual Mentor. The brainchild of Audiey Kao, MD, PhD, vice president of ethics at the AMA, Virtual Mentor was created with a focus on serving students and trainees in medicine. (Full disclosure: both of us were working in the AMA's ethics group at the time, and we each contributed pieces to early issues of the Virtual Mentor, but we were not involved in creating it.) In 2015, the Virtual Mentor was rebranded as the AMA Journal of Ethics, reflecting the journal's maturity into an indexed, professional journal that, while still using learners as editors, also published peer-reviewed work by leading bioethicists, clinicians, and academics.
Why Did the AMA Kill its Journal of Ethics?
The AMA is the nation's largest and most influential medical professional organization, and its Journal of Ethics held the mission of, "illuminating the art of medicine" by being an open access journal, freely available to all, with no advertising, focusing each month on an important ethical issue in healthcare, and, most uniquely perhaps, each issue was edited by health professional trainees and their mentors. Only the AMA, with its mission, resources, and reach, could have produced this journal.
One possible reason for its elimination might be financial. But if financial returns were to be a metric for success, then the AMA JoE had a bad business model from the start: no fees, no subscriptions, no advertising. As Kao argued, a guiding premise for the journal was that "ethics inquiry is a public good" -- hence no fees or subscriptions and no ads (avoiding conflicts of interest is critical in ethics inquiry).
For the AMA, the business case for AMA JoE could never have been about profit; rather, it was about demonstrating the AMA's integrity, altruism, and service to physicians from very early in their careers. The journal aimed to build goodwill, bolster the AMA's reputation, improve ethical deliberation within the profession and, most importantly, entice students and trainees to engage seriously with the organization. By these metrics it has succeeded. Over its more than 25 years in existence, the journal drew innumerable medical students, residents, and fellows into the AMA. It also provided a crucial training ground for young people in medicine who wanted to learn about bioethics and about writing and editing, and it helped build the credibility and presence of the AMA and its ethics group nationally and internationally.
So, if it wasn't about profit, perhaps it was the political environment. The journal encouraged medical trainees to explore some of the most contentious challenges facing medicine and society, so it inherently provided opportunities for controversy. Issues this year have addressed themes of private equity in medicine, regret and surgical professionalism, and evidence-based design in healthcare. Meanwhile, issues in prior years have addressed some currently inflammatory topics, like ethical issues related to transgender surgical care and segregation in healthcare. Remarkably, the journal still very rarely caused public relations problems for the AMA, perhaps because its editorial staff were highly qualified professionals, but also because its approach to controversy was civil, inquisitive, and exploratory.
As Kao wrote in a farewell essay this month: "For over a quarter of a century, the AMA Journal of Ethics has striven to publish insightful commentaries, engaging podcasts, and provocative artwork that help medical students, physicians, and all health care professionals reflect on and make sound ethical decisions in service to patients and society." In fact, the journal often demonstrated exactly this spirit of respectful discussion about challenging ethical issues that we need to rekindle today, making its loss even more tragic and difficult to explain.
AMA JoE: A Value-Added Offering
In a recent opinion piece in MedPage Today, "Medical Societies Are Facing an Existential Crisis," the authors exhorted medical societies, facing declining memberships and engagement among young physicians, to reimagine their role by offering "free basic memberships supplemented by value-added services [that] could attract early-career physicians who might otherwise remain disengaged." AMA JoE was exactly this type of value-added offering that not only served students and trainees, but also educators across health professions. Anecdotally, many health profession educators we know routinely use pieces from AMA JoE in their teaching and now lament its demise.
The AMA has reportedly promised to keep the historical content of the journal accessible on the AMA JoE website. This is no consolation for the students, residents, and fellows who were working on future issues, but it means the legacy of the journal will live on. Someday, we'd like to believe it might even be revived.
For now, we mourn the loss of AMA JoE for the field of bioethics. Even more, we mourn what the AMA's sudden elimination of its ethics journal might mean for physicians, the profession, and the public.
Matthew Wynia, MD, MPH, is a professor at the University of Colorado School of Medicine and Colorado School of Public Health and director of the Center for Bioethics and Humanities at the University of Colorado, Anschutz Medical Campus. Kayhan Parsi, JD, PhD, is a professor and graduate program director at the Neiswanger Institute for Bioethics at the Loyola University Chicago Stritch School of Medicine. He is also the John B. Francis co-chair in Bioethics at the Center for Practical Bioethics.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















